-
Radioimmunotherapy (RIT) uses an
antibody labeled with a
radionuclide to
deliver cytotoxic radiation to a
target cell. It is a form of
unsealed source...
-
specific cells, or to
bring a drug to a
specific cell type (such as with
radioimmunotherapy which delivers cytotoxic radiation).
Major applications include cancer...
- taɪˈʌksɛtæn/), sold
under the
trade name Zevalin, is a
monoclonal antibody radioimmunotherapy treatment for non-Hodgkin's lymphoma. The drug uses the monoclonal...
- calretinin. For
cancers that
highly express CEA,
targeting CEA
through radioimmunotherapy is one of the
therapy approaches.
Engineered antibodies such as single-chain...
- PMID 12433039. Mausner,
Leonard F. (1993). "Selection of
radionuclides for
radioimmunotherapy".
Medical Physics. 20 (2): 503–509. Bibcode:1993MedPh..20..503M. doi:10...
-
pretargeted radioimmunotherapy.
Animal studies have been
conducted as well as
clinical studies in humans. In
pretargeted radioimmunotherapy, two or three...
-
classes of
treatments in
general use: chemotherapy, immunotherapy,
radioimmunotherapy and
biologic agents. The
phases of
treatment are generally: frontline...
-
Hnatowich DJ (September 1987). "Generator-produced yttrium-90 for
radioimmunotherapy".
Journal of
Nuclear Medicine. 28 (9): 1465–70. CiteSeerX 10.1.1.543...
- the town of
Henrietta in the Rochester, New York
metropolitan area.
Radioimmunotherapy,
radioisotope therapy with
monoclonal antibodies Radioisotope therapy...
-
reduce the rate of
local recurrence but does not
prolong survival.
Radioimmunotherapy of
metastatic melanoma is
currently under investigation. Radiotherapy...
